Clinical Trials
7
Active:3
Completed:4
Trial Phases
2 Phases
Phase 1:3
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (60.0%)Phase 2
2 (40.0%)Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight Neonates for Prevention of Staphylococcal Sepsis
- First Posted Date
- 2008-03-28
- Last Posted Date
- 2011-10-24
- Lead Sponsor
- Biosynexus Incorporated
- Target Recruit Count
- 1579
- Registration Number
- NCT00646399
- Locations
- 🇺🇸
Biosynexus Incorporated, Gaithersburg, Maryland, United States
Safety and Pharmacokinetics Study in Adults for the Prevention of S. Epidermidis Infection in Low Birth Weight Infants
- First Posted Date
- 2008-03-14
- Last Posted Date
- 2008-10-09
- Lead Sponsor
- Biosynexus Incorporated
- Target Recruit Count
- 8
- Registration Number
- NCT00636285
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity Study in VLBW Neonates of BSYX-A110
- First Posted Date
- 2008-03-10
- Last Posted Date
- 2008-03-10
- Lead Sponsor
- Biosynexus Incorporated
- Target Recruit Count
- 88
- Registration Number
- NCT00631800
- Locations
- 🇺🇸
Texas Children's Hospital/Ben Taub Hospital (Baylor College of Medicine), Houston, Texas, United States
Safety and Pharmacokinetics Study in VLBW Neonates With BSYX-A110
Phase 1
Completed
- Conditions
- Neonatal Staphylococcal Sepsis
- Interventions
- First Posted Date
- 2008-03-10
- Last Posted Date
- 2008-03-10
- Lead Sponsor
- Biosynexus Incorporated
- Target Recruit Count
- 53
- Registration Number
- NCT00631878
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
News
No news found